Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience | European
Respiratory Society Skip to main content Main menu Home Current issue Early View Archive …

Inhaled corticosteroids (ICS) are used as anti-inflammatory controller therapy given either
alone or in a combination with long-acting bronchodilators for persistent asthma. The novel …

Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), has become a real pandemic. After a median incubation period of 5 days …

Background: The impact of inhaled corticosteroid (ICS) in the interaction between asthma,
COVID-19 and COVID-19 associated outcomes remain largely unknown. The objective of …

BACKGROUND: Asthma is a common chronic inflammatory respiratory disease more
common in children. Microbial agents such as viruses are a common trigger of asthma …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection is a new rapidly spreading infectious disease. Current …

Abstract Coronavirus disease 2019 (COVID-19) continues to spread across the world. Since
the beginning of the pandemic, the question of whether asthma is a risk factor for getting the …

Purpose It is unclear whether asthma is a risk factor for the development of COVID-19;
however, severe asthma is a risk factor for morbidity and mortality. While systemic …

Background There is conflicting evidence regarding the effect of asthma and its different
therapeutic options on COVID-19 severity and the clinical outcomes. Aim This study aimed …

Background Inhaled corticosteroids have been widely reported as a preventive measure
against the development of severe forms of COVID-19 not only in patients with asthma …